# Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

> **NCT02220829** · PHASE3 · COMPLETED · sponsor: **Sir Mortimer B. Davis - Jewish General Hospital** · enrollment: 148 (actual)

## Conditions studied

- Urinary Problems
- Prostate Cancer

## Interventions

- **DRUG:** Preventive administration of Rapaflo
- **DRUG:** Standard Care

## Key facts

- **NCT ID:** NCT02220829
- **Lead sponsor:** Sir Mortimer B. Davis - Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2023-04
- **Final completion:** 2023-08
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02220829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02220829, "Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02220829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*